Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9



Status:Completed
Conditions:Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:21 - 50
Updated:1/13/2017
End Date:August 2000

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Trial of Buprenorphine/Naloxone for Treatment of Opiate Dependence

The purpose of this study is to determine the efficacy and safety of a
buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for
opiate-dependence treatment.


Inclusion Criteria:

M/F ages 21-50. Meet DSM-IV criteria for opiate dependence. Agree to conditions of the
study and sign informed consent.

Exclusion Criteria:

Psychiatric disorder that requires medication therapy. History of seizures. Pregnant
and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics.
Acute hepatitis. Other medical condtions that deem participation to be unsafe.
We found this trial at
1
site
Friends Research Institute
Los Angeles, California 90025
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials